Targeting of alpha-v integrins reduces malignancy of bladder carcinoma. [electronic resource]
Producer: 20160104Description: e108464 p. digitalISSN:- 1932-6203
- Aldehyde Dehydrogenase -- biosynthesis
- Animals
- Carcinoma, Transitional Cell -- pathology
- Cell Adhesion -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Self Renewal -- drug effects
- Epithelial-Mesenchymal Transition -- drug effects
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Genetic Vectors -- pharmacology
- Heart
- Humans
- Integrin alphaV -- drug effects
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Molecular Targeted Therapy
- Neoplasm Invasiveness
- Neoplasm Proteins -- antagonists & inhibitors
- Neoplasm Transplantation -- methods
- Papilloma -- pathology
- RNA Interference
- RNA, Small Interfering -- pharmacology
- Receptors, Vitronectin -- antagonists & inhibitors
- Tibia
- Transcription Factors -- biosynthesis
- Transduction, Genetic
- Tumor Stem Cell Assay
- Urinary Bladder Neoplasms -- pathology
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.